Literature DB >> 35332263

A single-cell atlas of non-haematopoietic cells in human lymph nodes and lymphoma reveals a landscape of stromal remodelling.

Yoshiaki Abe1, Mamiko Sakata-Yanagimoto2,3,4, Manabu Fujisawa5, Hiroaki Miyoshi6, Yasuhito Suehara7, Keiichiro Hattori7, Manabu Kusakabe5,7, Tatsuhiro Sakamoto5,7, Hidekazu Nishikii5,7, Tran B Nguyen5, Yohei Owada8, Tsuyoshi Enomoto8, Aya Sawa9, Hiroko Bando10, Chikashi Yoshida11, Rikako Tabata12, Toshiki Terao12, Masahiro Nakayama13, Koichi Ohshima6, Kensuke Usuki14, Tatsuya Oda8, Kosei Matsue12, Shigeru Chiba15,16.   

Abstract

The activities of non-haematopoietic cells (NHCs), including mesenchymal stromal cells and endothelial cells, in lymphomas are reported to underlie lymphomagenesis. However, our understanding of lymphoma NHCs has been hampered by unexplained NHC heterogeneity, even in normal human lymph nodes (LNs). Here we constructed a single-cell transcriptome atlas of more than 100,000 NHCs collected from 27 human samples, including LNs and various nodal lymphomas, and it revealed 30 distinct subclusters, including some that were previously unrecognized. Notably, this atlas was useful for comparative analyses with lymphoma NHCs, which revealed an unanticipated landscape of subcluster-specific changes in gene expression and interaction with malignant cells in follicular lymphoma NHCs. This facilitates our understanding of stromal remodelling in lymphoma and highlights potential clinical biomarkers. Our study largely updates NHC taxonomy in human LNs and analysis of disease status, and provides a rich resource and deeper insights into LN and lymphoma biology to advance lymphoma management and therapy.
© 2022. The Author(s).

Entities:  

Mesh:

Year:  2022        PMID: 35332263      PMCID: PMC9033586          DOI: 10.1038/s41556-022-00866-3

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.213


  80 in total

Review 1.  Targeting the tumour stroma to improve cancer therapy.

Authors:  Kenneth C Valkenburg; Amber E de Groot; Kenneth J Pienta
Journal:  Nat Rev Clin Oncol       Date:  2018-06       Impact factor: 66.675

Review 2.  Microenvironmental regulation of tumour angiogenesis.

Authors:  Michele De Palma; Daniela Biziato; Tatiana V Petrova
Journal:  Nat Rev Cancer       Date:  2017-07-14       Impact factor: 60.716

3.  Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B-cell activating factor and activation of the canonical and non-canonical nuclear factor κB pathways.

Authors:  Daniel J Medina; Lauri Goodell; John Glod; Céline Gélinas; Arnold B Rabson; Roger K Strair
Journal:  Haematologica       Date:  2012-02-27       Impact factor: 9.941

Review 4.  Targeting the Tumor Microenvironment of Leukemia and Lymphoma.

Authors:  Uta E Höpken; Armin Rehm
Journal:  Trends Cancer       Date:  2019-06-05

Review 5.  Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma.

Authors:  J Ruan; K Hajjar; S Rafii; J P Leonard
Journal:  Ann Oncol       Date:  2008-12-16       Impact factor: 32.976

Review 6.  The tumour microenvironment in B cell lymphomas.

Authors:  David W Scott; Randy D Gascoyne
Journal:  Nat Rev Cancer       Date:  2014-07-10       Impact factor: 60.716

Review 7.  Follicular lymphoma.

Authors:  Antonino Carbone; Sandrine Roulland; Annunziata Gloghini; Anas Younes; Gottfried von Keudell; Armando López-Guillermo; Jude Fitzgibbon
Journal:  Nat Rev Dis Primers       Date:  2019-12-12       Impact factor: 52.329

8.  Stromal gene signatures in large-B-cell lymphomas.

Authors:  G Lenz; G Wright; S S Dave; W Xiao; J Powell; H Zhao; W Xu; B Tan; N Goldschmidt; J Iqbal; J Vose; M Bast; K Fu; D D Weisenburger; T C Greiner; J O Armitage; A Kyle; L May; R D Gascoyne; J M Connors; G Troen; H Holte; S Kvaloy; D Dierickx; G Verhoef; J Delabie; E B Smeland; P Jares; A Martinez; A Lopez-Guillermo; E Montserrat; E Campo; R M Braziel; T P Miller; L M Rimsza; J R Cook; B Pohlman; J Sweetenham; R R Tubbs; R I Fisher; E Hartmann; A Rosenwald; G Ott; H-K Muller-Hermelink; D Wrench; T A Lister; E S Jaffe; W H Wilson; W C Chan; L M Staudt
Journal:  N Engl J Med       Date:  2008-11-27       Impact factor: 91.245

9.  Stromal cell contribution to human follicular lymphoma pathogenesis.

Authors:  Frédéric Mourcin; Céline Pangault; Rada Amin-Ali; Patricia Amé-Thomas; Karin Tarte
Journal:  Front Immunol       Date:  2012-09-05       Impact factor: 7.561

Review 10.  A framework for advancing our understanding of cancer-associated fibroblasts.

Authors:  Erik Sahai; Igor Astsaturov; Edna Cukierman; David G DeNardo; Mikala Egeblad; Ronald M Evans; Douglas Fearon; Florian R Greten; Sunil R Hingorani; Tony Hunter; Richard O Hynes; Rakesh K Jain; Tobias Janowitz; Claus Jorgensen; Alec C Kimmelman; Mikhail G Kolonin; Robert G Maki; R Scott Powers; Ellen Puré; Daniel C Ramirez; Ruth Scherz-Shouval; Mara H Sherman; Sheila Stewart; Thea D Tlsty; David A Tuveson; Fiona M Watt; Valerie Weaver; Ashani T Weeraratna; Zena Werb
Journal:  Nat Rev Cancer       Date:  2020-01-24       Impact factor: 60.716

View more
  2 in total

1.  Cell type-specific inference of differential expression in spatial transcriptomics.

Authors:  Rafael A Irizarry; Fei Chen; Dylan M Cable; Evan Murray; Vignesh Shanmugam; Simon Zhang; Luli S Zou; Michael Diao; Haiqi Chen; Evan Z Macosko
Journal:  Nat Methods       Date:  2022-09-01       Impact factor: 47.990

Review 2.  Angiogenesis goes computational - The future way forward to discover new angiogenic targets?

Authors:  Abhishek Subramanian; Pooya Zakeri; Mira Mousa; Halima Alnaqbi; Fatima Yousif Alshamsi; Leo Bettoni; Ernesto Damiani; Habiba Alsafar; Yvan Saeys; Peter Carmeliet
Journal:  Comput Struct Biotechnol J       Date:  2022-09-13       Impact factor: 6.155

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.